US 12,084,686 B2
Antibodies with modulated glycan profiles
Log In
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.
or Log in

General

US 12,084,686 B2
Antibodies with modulated glycan profiles
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
MARYAM MONSHIPOURI
Art Unit:
1651 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzyme
Agent:
AMGEN INC.
Inventors:
--
Assignee:
AMGEN INC.
Priority:
--
Filed:
04/30/19
Granted:
09/10/24
Expiration:
09/24/40
Cooperative Patent Classification (CPC)
C12C12N2500/34C12NC07K2317/14C07KA61K39/39591A61K

Analytics

Cases

Patent Assignments

Citations